Arş. Gör. TANER BABACAN

Yayın Ağı

Makaleler 59

1. Prognostic role of inflammatory biomarkers in metastatic breast cancer

Petekkaya I., Unlu O., Roach E. C., Gecmez G., Okoh A. K., BABACAN T., et al.

JOURNAL OF BUON , cilt.22, sa.3, ss.614-622, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients

Karatas F., Erdem G. U., Sahin S., Aytekin A., YÜCE D., SEVER A. R., et al.

BREAST , cilt.32, ss.237-244, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. A case of vemurafenib-induced polyarhritis in a patient with melanoma: how to manage it?

BABACAN T., Turkbeyler I. H., Balakan O., Pehlivan Y., Suner A., Kisacik B.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.20, sa.3, ss.398-401, 2017 (SCI-Expanded, Scopus)

4. Risk factors and histopathological features of breast cancer among women with different menopausal status and age at diagnosis

Unlu O., Kiyak D., Caka C., Yagmur M., Yavas H. G., Erdogan F., et al.

JOURNAL OF BUON , cilt.22, sa.1, ss.184-191, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Patients' understanding of treatment goals and disease course and their relationship with optimism, hope, and quality of life: a preliminary study among advanced breast cancer outpatients before receiving palliative treatment

SOYLU C., BABACAN T., SEVER A. R., Altundag K.

SUPPORTIVE CARE IN CANCER , cilt.24, sa.8, ss.3481-3488, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer

Karatas F., Sahin S., Erdem G. U., ATEŞ Ö., BABACAN T., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.851-858, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients

Ozen M., Gunduz M., ATEŞ Ö., BABACAN T., SEVER A. R., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.799-808, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience

Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded, Scopus)

9. Depression and socio-economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

Tanriverdi O., Yavuzsen T., Turhal S., Kilic D., YALÇIN S. S., Ozkan A., et al.

EUROPEAN JOURNAL OF CANCER CARE , cilt.25, sa.3, ss.502-515, 2016 (SCI-Expanded, SSCI, Scopus)

10. Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors

ATEŞ Ö., SOYLU C., BABACAN T., Sarici F., KERTMEN N., Allen D., et al.

SPRINGERPLUS , cilt.5, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Leg cramps associated with tamoxifen use - possible mechanism and treatment recommendations

Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.

JOURNAL OF BUON , cilt.21, sa.2, ss.520, 2016 (SCI-Expanded, Scopus)

12. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Prognostic Factors In Breast Cancer Patients With Hepatic Metastases: Impact Of Molecular Subtype And Local Hepatic Treatment

ATEŞ Ö., GÜVEN D. C., BABACAN T., Sunar V., Sarici F., AKSOY S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.4, ss.206-214, 2016 (SCI-Expanded, Scopus, TRDizin)

14. Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75

Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded, Scopus, TRDizin)

15. Insomnia caused by aromatase inhibitors; a therapeutic challenge in patients with breast cancer

Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.

JOURNAL OF BUON , cilt.20, sa.6, ss.1640, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Does eribulin mesylate cause recurrent transient diplopia?

Karatas F., Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.

JOURNAL OF BUON , cilt.20, sa.5, ss.1379, 2015 (SCI-Expanded, Scopus)

17. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer

BABACAN T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., Balakan O., et al.

TUMORI J , cilt.101, sa.4, ss.418-423, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. The effect of obesity on recurrence pattern in early breast cancer patients

Yazici O., AKSOY S., Sendur M. A. N., BABACAN T., Ozdemir N., Ozisik Y., et al.

JOURNAL OF BUON , cilt.20, sa.4, ss.954-962, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality

Solak M., Turkoz F. P., Keskin O., AKSOY S., BABACAN T., Sarici F., et al.

JOURNAL OF BUON , cilt.20, sa.3, ss.737-745, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Can aromatase inhibitors cause forgetfulness in women with breast cancer ?

Karatas F., AKIN S., BABACAN T., SEVER A. R., Altundag K.

JOURNAL OF BUON , cilt.20, sa.3, ss.935, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.

JOURNAL OF BUON , cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab

ATEŞ Ö., Sunar V., BABACAN T., AKIN S., KERTMEN N., Altundag K.

JOURNAL OF BUON , cilt.20, sa.1, ss.349, 2015 (SCI-Expanded, Scopus)

23. A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer

Buyukhatipoglu H., BABACAN T., KERTMEN N., Balakan O., Suner A., ATEŞ Ö., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.22-27, 2015 (SCI-Expanded, Scopus)

24. Molecular subtypes in patients with inflammatory breast cancer; A single center experience

KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Cerebellar Abscess In A Metastatic Esophageal Cancer Patient: A Rare Entity

BİLGİN E., BABACAN T., Zengin O., Gokduman K., MUTLU D.

EUROPEAN JOURNAL OF THERAPEUTICS , cilt.21, sa.1, ss.73-74, 2015 (ESCI, TRDizin) Sürdürülebilir Kalkınma

26. A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature

Keskin O. D., KERTMEN N., Karakas Y., BABACAN T., ARIK Z., Altundag K., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.348, 2015 (SCI-Expanded, Scopus)

27. The Synchronous Primary Carcinomas of the Rectum and Thymus

BABACAN T., Dag S., Sarici F., Dilli I., Turkbeyler I. H., Altundag K.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.2, ss.143-144, 2015 (SCI-Expanded, Scopus, TRDizin)

28. How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?

Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.

FUTURE ONCOLOGY , cilt.11, sa.20, ss.2799-2801, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Comparison of three different induction regimens for nasopharyngeal cancer

KERTMEN N., AKSOY S., CENGİZ M., YAZICI G., KESKİN O., Babacan T., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.1, ss.59-63, 2015 (SCI-Expanded, Scopus)

30. The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+breast cancer patients

BABACAN T., Balakan O., Kuzan T. Y., Sarici F., Koca E., KERTMEN N., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.50-56, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Acute erythroid leukemia in a patient with chronic lymphocytic leukemia

GÜVEN D. C., BABACAN T., Sarici F., AKIN S., Altundag K., Turker A.

JOURNAL OF BUON , cilt.19, sa.4, ss.1127, 2014 (SCI-Expanded, Scopus)

32. The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer

Balakan O., KALENDER M. E., Suner A., Cengiz B., ÖZTUZCU S., Bayraktar R., et al.

MEDICAL SCIENCE MONITOR , cilt.20, ss.1419-1425, 2014 (SCI-Expanded, Scopus)

33. Impact of inflammatory markers on the prognosis of patients with operable breast cancer

Petekkaya I., AKSOY S., Roach E. C., Okoh A. K., Gecmez G., Gezgen G., et al.

JOURNAL OF BUON , cilt.19, sa.3, ss.673-680, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Breast sarcoma: A rare malignancy

Gul G., BABACAN T., AKIN S., Sarici F., Altundag K.

JOURNAL OF BUON , cilt.19, sa.2, ss.577, 2014 (SCI-Expanded, Scopus)

35. Tertiary Cancer Center Experience: Pregnancy-Associated Breast Cancer

Kuzas T. Y., Koca E., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.284-285, 2014 (SCI-Expanded, Scopus, TRDizin)

36. A novel targeted therapy in breast cancer: Cyclin dependent kinase inhibitors

AKIN S., BABACAN T., Sarici F., Altundag K.

JOURNAL OF BUON , cilt.19, sa.1, ss.42-46, 2014 (SCI-Expanded, Scopus)

37. Successful treatment of myeloid sarcoma with local treatment modalities: The longest overall survival in published literature

Aladag E., Babacan T., Akin S., Uner U., Kars A., Altundag K.

JOURNAL OF BUON , cilt.19, sa.1, ss.316-317, 2014 (SCI-Expanded, Scopus)

38. Cetuximab-induced esophageal ulcer: the first report in literature

BABACAN T., Turkbeyler I. H., Dag M. S., Dilli I., Balakan O., Altundag K.

LIBYAN JOURNAL OF MEDICINE , cilt.9, 2014 (SCI-Expanded, Scopus)

39. Metaplastic Breast Carcinoma: a Heterogeneous Disease

GÜLTEKİN M., Eren G., Babacan T., YILDIZ F., Altundag K., GÜLER N., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.6, ss.2851-2856, 2014 (SCI-Expanded, Scopus)

40. Impact of the obesity on lymph node status in operable breast cancer patients

Keskin O., Aksoy S., Babacan T., Sarici F., Kertmen N., Solak M., et al.

JOURNAL OF BUON , cilt.18, sa.4, ss.824-830, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Outcomes of locally advanced breast cancer patients with >= 10 positive axillary lymph nodes

KOCA E., KUZAN T. Y., Dizdar O., Babacan T., SAHIN I., ARARAT E., et al.

MEDICAL ONCOLOGY , cilt.30, sa.3, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Bilateral transient regional osteoporosis of the hip: case report

Sarica M. A., Turkbeyler I. H., BABACAN T., TOSUN H. B., Bulut T.

EUROPEAN JOURNAL OF THERAPEUTICS , cilt.19, sa.3, ss.207-209, 2013 (ESCI, TRDizin) Sürdürülebilir Kalkınma

43. Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents

Sarici F., Babacan T., Altundag K., Balakan O., Gullu I.

JOURNAL OF BUON , cilt.18, sa.3, ss.799, 2013 (SCI-Expanded, Scopus)

44. Medullary carcinoma of the breast: A brief report from a tertiary care center

Petekkaya I., Babacan T., Sarici F., Gezgen G., Roach E. C., Kizilarslanoglu M. C., et al.

JOURNAL OF BUON , cilt.18, sa.3, ss.798, 2013 (SCI-Expanded, Scopus)

45. Association between common risk factors and molecular subtypes in breast cancer patients

Turkoz F. P., Solak M., Petekkaya I., Keskin O., KERTMEN N., Sarici F., et al.

BREAST , cilt.22, sa.3, ss.344-350, 2013 (SCI-Expanded, Scopus)

46. Granulocyte colony stimulating factor-induced tumor lysis-like syndrome: leucolysis

Babacan T., Sarici F., Gokhan A., Balakan O., Keskin O., Altundag K.

JOURNAL OF BUON , cilt.18, sa.2, ss.549-550, 2013 (SCI-Expanded, Scopus)

47. Adult Langerhans' cell histiocytosis: a rare cause of parotid gland enlargement

Babacan T., Turkbeyler I. H., Zengin O., Gokhan A., Sarici F., Altundag K.

JOURNAL OF BUON , cilt.18, sa.2, ss.546-547, 2013 (SCI-Expanded, Scopus)

48. Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer

Boyraz B., Sendur M. A. N., AKSOY S., BABACAN T., Roach E. C., KIZILARSLANOĞLU M. C., et al.

CURRENT MEDICAL RESEARCH AND OPINION , cilt.29, sa.4, ss.405-414, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women

Turkoz F. P., Solak M., Petekkaya I., Keskin O., Kertmen N., Sarici F., et al.

JOURNAL OF BUON , cilt.18, sa.2, ss.335-341, 2013 (SCI-Expanded, Scopus)

50. Vemurafenib-induced hypertension: is it real?

Balakan O., Babacan T., Altundag K.

JOURNAL OF BUON , cilt.18, sa.2, ss.545, 2013 (SCI-Expanded, Scopus)

51. Colon involvement in a chronic lymphocytic leukemia patient

Sarici F., Babacan T., Petekkaya I., Gezgen G., Roach E. C., Altundag K.

JOURNAL OF BUON , cilt.18, sa.1, ss.291-292, 2013 (SCI-Expanded, Scopus)

52. Safety of Tamoxifen During Pregnancy: 3 Case Reports and Review of the Literature

Koca E., Kuzan T. Y., BABACAN T., Turkbeyler I. H., Sarici F., Altundag K.

BREAST CARE , cilt.8, sa.6, ss.453-454, 2013 (SCI-Expanded, Scopus)

53. Frequency of thyroid disease among breast cancer patients: a descriptive study of breast cancer patients

Vural O., Dizdar O., Petekkaya I., Alnak A., Babacan T., Altundag K.

JOURNAL OF BUON , cilt.18, sa.1, ss.294-295, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Association between family history and clinicopathologic characteristics in 1987 breast cancer patients: single institution experience from Turkey

Turkoz F. P., Solak M., Aksoy S., Petekkaya I., Keskin O., Kertmen N., et al.

JOURNAL OF BUON , cilt.17, sa.4, ss.649-657, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Comparison of clinicopathological characteristics and outcome of younger and older breast cancer patients

Kertmen N., Sahin U., Keskin O., Solak M., Petekkaya I., Babacan T., et al.

JOURNAL OF BUON , cilt.17, sa.4, ss.797, 2012 (SCI-Expanded, Scopus)

56. Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor

Kuria I. M., Petekkaya I., Hasanov E., Babacan T., Dizdar O., Altundag K.

JOURNAL OF BUON , cilt.17, sa.4, ss.798-799, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Vismodegib in Advanced Basal-Cell Carcinoma

BABACAN T., Sarici F., Altundag K.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.367, sa.10, ss.969-970, 2012 (SCI-Expanded, Scopus)

58. Clinical and pathological characteristics of patients 80 years and older with breast cancer

Tosur M., Sahin I., Ararat E., Babacan T., Altundag K.

JOURNAL OF BUON , cilt.17, sa.2, ss.397-398, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Sunitinib-Induced Autoimmune Thyroiditis in a Patient with Metastatic Renal Cell Carcinoma: A Case Report

Babacan T., Sevinc A., Akarsu E., Balakan O.

CHEMOTHERAPY , cilt.58, sa.2, ss.142-145, 2012 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 22

1. Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study

DEMİRCİ N., AKSOY S., ÖZDEMİR N., Babacan T., ERDEM G. U., BOZKAYA Y., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

2. Pleomorphic lobular carcinoma of the breast associated with impaired overall survival

Hacioglu M. B., Babacan T., Diker O., Akin S., Demir M., Dizdar O., et al.

European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)

3. Kadri Altundag Taner Babacan Orhan Efe Ahmet S Hasırcı Fatih Demirci Hakan Buyukhatıpoglu Ozan Balakan Furkan Saim Sarıcı Neyran Kertmen Ece Esin Serkan Akin Ozturk Ates Sercan Aksoy Ali R Sever

ALTUNDAĞ M. K., Babacan T., EFE O., HASIRCI A. S., DEMİRCİ F., BUYUKHATİPOGLU H., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)

4. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

Ateş Ö., Babacan T., SARICI F., KERTMEN N., CENOLİ A., Akın S., et al.

ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

5. Tumor locations significantly affect disease free survival and overall survival

BUYUKHATİPOGLU H., Babacan T., KERTMEN N., Ateş Ö., AKTAŞ G., ŞENDUR M. A. N., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)

6. Factors that affect the suitability of cancer patients for clinical drug trials in Turkey: Final analysis of a multicenter study.

Erman M., Kilickap S., Ekinci A. S., Koca S., Ata A., Besen A., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.

Diker O., Babacan T., Buyukhatipoglu H., Kertmen N., Balakan O., Sever A. R., et al.

8. Efficacy of adjuvant tamoxifen in hormone receptor-positive premenopausal breast cancer patients according to the body mass index

Altundag K., Sendur M. A. N., AKSOY S., BABACAN T., Ozisik Y.

37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 9 - 13 Aralık 2014, cilt.75, (Özet Bildiri) Sürdürülebilir Kalkınma